# Beclomethasone-Formoterol

## Foster 100/6mcg/dose

| 藥物代碼 | EFOS |
| :--- | :--- |
| 適應症 | Regular treatment of asthma for patients not adequately controlled w/ inhaled corticosteroid & inhaled short-acting β2-agonists; patients adequately controlled on both inhaled corticosteroids & long-acting β2-agonists. |
| 副作用 | Pharyngitis, headache, dysphonia.CommonCardiovascular: Chest pain \(1.9% to 3.2% \), PalpitationsGastrointestinal: Diarrhea \(4.9% \), Nausea \(4.9% \), Xerostomia \(1.3% to 3.3% \)Neurologic: Dizziness \(0.9% to 2.4% \), Headache \(Less than 5% ; oral inhalation, 8% to 25% \), Insomnia \(1.5% to 2.4% \), Tremor \(1.9% to 8.6% \)SeriousCardiovascular: Cardiac dysrhythmiaRespiratory: Death, Asthma-related, Exacerbation of asthma \(Severe\)Endocrine metabolic: Hypocortisolism secondary to another disorder, Type 2 diabetes mellitusImmunologic: Hypersensitivity reaction, ImmunosuppressionOphthalmic: Cataract, GlaucomaRespiratory: Bronchospasm |
| 禁忌 | Hypersensitivity. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | Asthma: Adult &gt;=18 yr: 1 or 2 inhalations bid. Max daily dose: 4 inhalations. Adult &gt;=18 yr: Patients should take 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. The maximum daily dose is 8 inhalations. COPD: Adult &gt;=18 yr: 2 inhalations bid. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | BECLOMETHASONE PREGNANCY RECOMMENDATION: Compatible FORMOTEROL PREGNANCY RECOMMENDATION: Limited Human Data—Probably Compatible |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | BECLOMETHASONE BREASTFEEDING RECOMMENDATION: Limited Human Data—Probably Compatible FORMOTEROL BREASTFEEDING RECOMMENDATION: No Human Data—Probably Compatible |
| 注射劑給藥建議途徑 | IH |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 發藥前：請儲存於冰箱（2-8°C）（最長可存放 18 個月）。 發藥後：請勿儲存於 25°C 以上環境（最長可存放 3 個月）。 |

## Foster Nexthaler 100/6mcg/dose

| 藥物代碼 | EFOSN |
| :--- | :--- |
| 適應症 | Regular treatment of asthma for patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short-acting β2-agonist or on both inhaled corticosteroids & long-acting β2-agonists. |
| 副作用 | Tremor, pneumonia \(in COPD patients\)CommonCardiovascular: Chest pain \(1.9% to 3.2% \), PalpitationsGastrointestinal: Diarrhea \(4.9% \), Nausea \(4.9% \), Xerostomia \(1.3% to 3.3% \)Neurologic: Dizziness \(0.9% to 2.4% \), Headache \(Less than 5% ; oral inhalation, 8% to 25% \), Insomnia \(1.5% to 2.4% \), Tremor \(1.9% to 8.6% \)SeriousCardiovascular: Cardiac dysrhythmiaRespiratory: Death, Asthma-related, Exacerbation of asthma \(Severe\)Endocrine metabolic: Hypocortisolism secondary to another disorder, Type 2 diabetes mellitusImmunologic: Hypersensitivity reaction, ImmunosuppressionOphthalmic: Cataract, GlaucomaRespiratory: Bronchospasm |
| 禁忌 | Hypersensitivity. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Asthma: Adult &gt;=18 yr: 1 or 2 inhalations bid. Max daily dose: 4 inhalations. Adult &gt;=18 yr: Patients should take 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. The maximum daily dose is 8 inhalations. COPD: Adult &gt;=18 yr: 2 inhalations bid. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | BECLOMETHASONE PREGNANCY RECOMMENDATION: Compatible FORMOTEROL PREGNANCY RECOMMENDATION: Limited Human Data—Probably Compatible |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | BECLOMETHASONE BREASTFEEDING RECOMMENDATION: Limited Human Data—Probably Compatible FORMOTEROL BREASTFEEDING RECOMMENDATION: No Human Data—Probably Compatible |
| 注射劑給藥建議途徑 | IH, INHL |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

